Ontology highlight
ABSTRACT: Introduction
Chronic inflammatory diseases (CIDs) are frequently treated with biological medications, specifically tumour necrosis factor inhibitors (TNFi)). These medications inhibit the pro-inflammatory molecule TNF alpha, which has been strongly implicated in the aetiology of these diseases. Up to one-third of patients do not, however, respond to biologics, and lifestyle factors are assumed to affect treatment outcomes. Little is known about the effects of dietary lifestyle as a prognostic factor that may enable personalised medicine. The primary outcome of this multidisciplinary collaborative study will be to identify dietary lifestyle factors that support optimal treatment outcomes.Methods and analysis
This prospective cohort study will enrol 320 patients with CID who
SUBMITTER: Christensen R
PROVIDER: S-EPMC5829767 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature